Epigenica AB, a pioneer in high-throughput epigenetic screening tools and solutions, has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures, with participation from co-investors Navigare Ventures, Leksell Social Ventures, and current shareholder Almi Invest. With powerful new tools, ... The post Voima Ventures leads $2.2 Million Investment Round in Epigenica to enable paradigm shift in personalised medic...
